David Ferreiro is Executive Director and Senior Analyst at Oppenheimer & Co. Inc., covering biotechnology, life science tools and diagnostics, and in 2012 was voted best up-and-coming Life Science Tools & Diagnostics Analyst fromInstitutional Investor’s All-America’s Research Team. Prior to Oppenheimer & Co. Inc., Dr. Ferreiro worked at JMP Securities on the medical devices research team. He began his Wall Street career at Banc of America Securities LLC covering biotechnology. Previously, he was a Graduate Research Scientist at Albert Einstein College of Medicine. Dr. Ferreiro holds a B.A. in biology from Middlebury College, and an M.S. and a Ph.D. in microbiology and immunology from the Albert Einstein College of Medicine.
Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013